Clinical Trials

The Weight Loss Breakthrough: New Drug Combo Delivers 22.7% Body Weight Loss

A new semaglutide + cagrilintide combo (CagriSema) achieved up to 22.7% body weight loss in phase 3 trials, outperforming Ozempic alone. Here's what the data really say and who it's for.